Erythropoietin or darbepoetin for patients with cancer
2,919 results
1 - 100
Erythropoietin or darbepoetin for patients with cancer- Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data
Erythropoietin or darbepoetin for patients with malignant disease - Infections in immunosuppressed and cancer patients
- Psychosocial support for patients with cancer
- Thymic peptides for treatment of cancer patients
- Parenteral anticoagulation in ambulatory patients with cancer
- Cardioprotective interventions for cancer patients receiving anthracyclines
- Treatment of depression in cancer patients
Phlebotomy decreased cancer risk in patients with PAD- Aromatherapy and massage for symptom relief in patients with cancer
- COVID-19 research brief: COVID-19 mortality in currently treated cancer patients not higher than in other cancer patients
- Testing for cancer in patients with unprovoked venous thromboembolism
- Preventing oral candidiasis in cancer patients
- Treating oral candidiasis in cancer patients
- Erythropoiesis stimulation increases death risk in cancer patients
- Parenteral anticoagulation in ambulatory patients with cancer
- Risk of cancer is low in patients with Barrett's esophagus
- No increased incidence of cancer in patients with superficial phlebitis
- Information interventions for orienting patients and their carers to cancer care facilities
- Different anthracycline derivates for reducing cardiotoxicity in cancer patients
- Strategies for detecting colon cancer in patients with inflammatory bowel disease
- Methods of communicating a primary diagnosis of breast cancer to patients
- Voriconazole versus amphotericin B in cancer patients with neutropenia
- Immunonutrition for patients undergoing surgery for head and neck cancer
- Treating H. pylori infection in close relatives of patients with gastric cancer prevents gastric cancer
- Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients
- Timing of breast surgery in premenopausal breast cancer patients
- Increased cancer risk in patients with myotonic muscular dystrophy
- Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia
- Subsequent colon cancer is rare in older patients with polyps
- Pay attention to gut feelings about cancer in patients
- Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
- Psychotherapy for depression among incurable cancer patients: Cochrane systematic review
- Interventions for preventing oral candidiasis for patients with cancer receiving treatment
- Methylphenidate, hematopoietic agents helpful in cancer-related fatigue
- Interventions for preventing oral mucositis for patients with cancer receiving treatment
- Interventions to enhance return-to-work for cancer patients
- Blood transfusions for anaemia in patients with advanced cancer: Cochrane systematic review
- Duration of adjuvant chemotherapy for patients with non‐metastatic colorectal cancer
- Follow‐up strategies for patients treated for non‐metastatic colorectal cancer
- Opioids for the management of breakthrough pain in cancer patients
- Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer
- Supportive care for patients with gastrointestinal cancer: Cochrane systematic review
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
- Patient‐reported outcome measures for follow‐up after gynaecological cancer treatment
- Anterior versus posterior mediastinal reconstruction after esophagectomy for patients with esophageal cancer
- Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer
- Psychosocial interventions for patients with head and neck cancer: Cochrane systematic review
- Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
- Chinese medicinal herbs to treat the side‐effects of chemotherapy in breast cancer patients
- Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
- Routine versus selective antifungal administration for control of fungal infections in patients with cancer
- Dance/movement therapy for improving psychological and physical outcomes in cancer patients
- Non‐invasive interventions for improving well‐being and quality of life in patients with lung cancer
- Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer
- Oral anticoagulation for prolonging survival in patients with cancer
- SR: limited data on acupuncture for control of hot flashes in patients with cancer
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Nicotinamide reduces recurrent nonmelanoma skin cancers in high-risk patients
- Warfarin doesn't prevent catheter-associated clots in cancer patients (WARP)
- Prevention of oral mucositis in patients receiving treatment for cancer
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
- Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
- Selenium not helpful for patients with bladder cancer; vitamin E may be harmful
- Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer
- CT colonography detects 85% of large polyps in patients at increased risk of colon cancer
- Empirical anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients
- Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
- Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer
- H. pylori treatment, vitamins prevent gastric cancer in high risk patients
- Follow-up strategies for patients treated for non-metastatic colorectal cancer
- Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients
- Patients experience shame and isolation for deciding not to pursue thyroid cancer treatment
- Routine versus selective antifungal administration for control of fungal infections in patients with cancer
- Lorazepam added to haloperidol effective for agitated delirium in end-of-life cancer patients
- Six clinical variables in patients with dysphagia identify decreased esophageal cancer risk
- Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission
- American College of Physicians: Screen for colon cancer using the test the patient chooses
- Empirical antibiotics targeting gram‐positive bacteria for the treatment of febrile neutropenic patients with cancer
- New screening test for nasopharyngeal cancer accurate but not proven to improve patient outcomes
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
- Lung cancer screening requires additional imaging in 40% of patients in real world
- Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer
- Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia
- The role of iron in the management of chemotherapy‐induced anemia in cancer patients receiving erythropoiesis‐stimulating agents
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy
- Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
- Surgery versus radiosurgery for patients with a solitary brain metastasis from non‐small cell lung cancer
- Mailing FIT or gFOBT directly to patients increases uptake of colorectal cancer screening
- Early versus late chest radiotherapy in patients with limited‐stage small cell lung cancer
- En‐bloc resection versus conventional transurethral resection for patients with non‐muscle‐invasive bladder cancer
- Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy